New task force criteria provide evolution in diagnosis of arrhythmogenic cardiomyopathy in patients without typical progression of the disease

0Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Objective: Unusual clinical course Background: The original Task Force Criteria from 1994 for the clinical diagnosis of ARVC were highly specific and based on structural, histological, EKG, and familial features of disease. However, recommendations for clinical diagnosis and management of ARVC are sparse and lacked sensitivity for early disease. Case Report: Ventricular electrical instability and sudden cardiac death are the hallmarks of ARVC, and are often present before structural abnormalities. In this case report, we describe a patient who had detectable electrical abnormalities and structural changes that remained unchanged for over 10 years. Conclusions: The disease progression in this case was defined as the development of a new 2010 TFC, which was absent at enrolment in 1994 and in 2008.

Cite

CITATION STYLE

APA

Parahuleva, M. S., Figiel, J., Ahrens, H., Schieffer, B., Divchev, D., & Lüsebrink, U. (2017). New task force criteria provide evolution in diagnosis of arrhythmogenic cardiomyopathy in patients without typical progression of the disease. American Journal of Case Reports, 18, 299–303. https://doi.org/10.12659/AJCR.901267

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free